Dr. Pascal Hänggi, Co-Founder and CSO of Polyneuron Pharmaceuticals AG, a Uni Basel Spin-off
Antibody-Catch - a novel therapeutic approach for autoimmune diseases
Start Date
19.10.2016 - 17:00
Event End
19.10.2016 - 18:00
Location
Universität Basel, Pharmazentrum
Antibody-Catch - a novel therapeutic approach for autoimmune diseases